Evidence for activation of microglia in patients with psychiatric illnesses
- PMID: 10477118
- DOI: 10.1016/s0304-3940(99)00545-5
Evidence for activation of microglia in patients with psychiatric illnesses
Abstract
Activation of microglia/macrophages is a key event in response to pathological changes in the CNS. HLA-DR is a valuable immunohistochemical marker that specifically reacts with activated microglia cells. In order to elucidate a potential role of microgliosis in severe psychiatric illnesses, post-mortem frontal cortex and hippocampus of patients with schizophrenia (n = 14) and affective disorder (n = 6) and control specimens (n = 13) were studied. Additionally Alzheimer's disease cases (n = 8) were included as a human model system with typical neurodegenerative alterations and microglia activation. All patient groups revealed subjects with abundant microglia immunostaining (schizophrenia, three patients; affective disorder, one patient; Alzheimer's disease, four patients) in both gray and white matter. This finding provides evidence for distinct neuropathological changes in brains of patients with schizophrenia and affective disorder. The activation of microglia cells, which represent a major part of the brain immune response, may help to unravel the pathophysiological processes in severe psychiatric illnesses.
Similar articles
-
Microglia activation in the brain as inflammatory biomarker of Alzheimer's disease neuropathology and clinical dementia.Dis Markers. 2006;22(1-2):95-102. doi: 10.1155/2006/276239. Dis Markers. 2006. PMID: 16410654 Free PMC article.
-
Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide.J Psychiatr Res. 2008 Jan;42(2):151-7. doi: 10.1016/j.jpsychires.2006.10.013. Epub 2006 Dec 15. J Psychiatr Res. 2008. PMID: 17174336
-
Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization.Acta Neuropathol. 2006 Sep;112(3):305-16. doi: 10.1007/s00401-006-0090-8. Epub 2006 Jun 17. Acta Neuropathol. 2006. PMID: 16783554
-
The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes.J Leukoc Biol. 2012 Nov;92(5):959-75. doi: 10.1189/jlb.0212100. Epub 2012 Aug 8. J Leukoc Biol. 2012. PMID: 22875882 Review.
-
Possible impact of microglial cells and the monocyte-macrophage system on suicidal behavior.CNS Neurol Disord Drug Targets. 2013 Nov;12(7):971-9. doi: 10.2174/18715273113129990099. CNS Neurol Disord Drug Targets. 2013. PMID: 24040799 Review.
Cited by
-
Microglia at the Tripartite Synapse during Postnatal Development: Implications for Autism Spectrum Disorders and Schizophrenia.Cells. 2023 Dec 13;12(24):2827. doi: 10.3390/cells12242827. Cells. 2023. PMID: 38132147 Free PMC article. Review.
-
Future perspectives on the treatment of cognitive deficits and negative symptoms in schizophrenia.World Psychiatry. 2013 Jun;12(2):99-107. doi: 10.1002/wps.20026. World Psychiatry. 2013. PMID: 23737409 Free PMC article.
-
Call for case histories of BMT in patients with coincident schizophrenia.Leukemia. 2013 Apr;27(5):1217-8. doi: 10.1038/leu.2013.32. Epub 2013 Feb 1. Leukemia. 2013. PMID: 23448966 Free PMC article. No abstract available.
-
Linking Activation of Microglia and Peripheral Monocytic Cells to the Pathophysiology of Psychiatric Disorders.Front Cell Neurosci. 2016 Jun 3;10:144. doi: 10.3389/fncel.2016.00144. eCollection 2016. Front Cell Neurosci. 2016. PMID: 27375431 Free PMC article. Review.
-
Deficiency of schnurri-2, an MHC enhancer binding protein, induces mild chronic inflammation in the brain and confers molecular, neuronal, and behavioral phenotypes related to schizophrenia.Neuropsychopharmacology. 2013 Jul;38(8):1409-25. doi: 10.1038/npp.2013.38. Epub 2013 Feb 6. Neuropsychopharmacology. 2013. PMID: 23389689 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials